Literature DB >> 17161255

Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography.

Cheuk-Man Yu1, Yat-Sun Chan, Qing Zhang, Gabriel W K Yip, Chi-Kin Chan, Leo C C Kum, LiWen Wu, Alex Pui-Wai Lee, Yat-Yin Lam, Jeffrey Wing-Hong Fung.   

Abstract

OBJECTIVES: This study was designed to evaluate the role of cardiac resynchronization therapy (CRT) in heart failure (HF) patients with narrow QRS complexes (<120 ms) and echocardiographic evidence of mechanical asynchrony.
BACKGROUND: Cardiac resynchronization therapy is currently recommended to advanced HF patients with prolonged QRS duration. Echocardiographic assessment of systolic mechanical asynchrony has been proven useful to predict a favorable response after CRT.
METHODS: A total of 102 HF patients with New York Heart Association (NYHA) functional class III or IV were enrolled. Among them, 51 had wide QRS (>120 ms) and 51 had narrow QRS (<120 ms). Tissue Doppler imaging (TDI) was employed to select patients with systolic asynchrony (increased asynchrony index) in the narrow-QRS group. Clinical and echocardiographic assessments were performed at baseline and 3 months after CRT.
RESULTS: There was a significant reduction of left ventricular (LV) end-systolic volume in both narrow (122 +/- 42 cc vs. 103 +/- 47 cc, p < 0.001) and wide (148 +/- 74 cc vs. 112 +/- 64 cc, p < 0.001) QRS groups. Improvement of NYHA functional class (both p < 0.001), maximal exercise capacity (both p < 0.05), 6-min hall-walk distance (both p < 0.01), ejection fraction (both p < 0.001), and mitral regurgitation (both p < 0.005) was also observed. In both groups, the degree of baseline mechanical asynchrony determined LV reverse remodeling to a similar extent, as shown by the superimposed regression lines. Withholding CRT for 4 weeks resulted in loss of echocardiographic benefits.
CONCLUSIONS: Cardiac resynchronization therapy for HF patients with narrow QRS complexes and coexisting mechanical asynchrony by TDI results in LV reverse remodeling and improvement of clinical status. The amplitude of benefit is similar to the wide-QRS group provided that similar extent of systolic asynchrony is selected.

Entities:  

Mesh:

Year:  2006        PMID: 17161255     DOI: 10.1016/j.jacc.2006.07.054

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  63 in total

1.  Acute and chronic response to CRT in narrow QRS patients.

Authors:  Tim Donahue; Imran Niazi; Angel Leon; Michael Stucky; Keith Herrmann
Journal:  J Cardiovasc Transl Res       Date:  2011-12-30       Impact factor: 4.132

2.  Increasing knowledge and changing views in cardiac resynchronization therapy.

Authors:  Laszlo Buga; John G F Cleland
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

Review 3.  Echocardiography, dyssynchrony, and the response to cardiac resynchronization therapy.

Authors:  Cheuk-Man Yu; John E Sanderson; John Gorcsan
Journal:  Eur Heart J       Date:  2010-08-13       Impact factor: 29.983

4.  Utility of three-dimensional echocardiography in assessing and predicting response to cardiac resynchronization therapy.

Authors:  Ching Lau; Husam Mohamed Abdel-Qadir; Ilan Lashevsky; Mark Hansen; Eugene Crystal; Campbell Joyner
Journal:  Can J Cardiol       Date:  2010-11       Impact factor: 5.223

5.  Single photon emission computed tomography (SPECT) techniques for resynchronization: phase analysis and equilibrium radionuclide angiocardiography.

Authors:  Kenneth C Bilchick
Journal:  J Nucl Cardiol       Date:  2011-02       Impact factor: 5.952

6.  Quantitative analysis of left ventricular dyssynchrony using cardiac computed tomography versus three-dimensional echocardiography.

Authors:  Sebastian J Buss; Felix Schulz; David Wolf; Waldemar Hosch; Christian Galuschky; Georg Schummers; Evangelos Giannitsis; Hans-Ulrich Kauczor; Christian Zugck; Ruediger Becker; Stefan E Hardt; Hugo A Katus; Grigorios Korosoglou
Journal:  Eur Radiol       Date:  2012-01-22       Impact factor: 5.315

7.  The resynchronization therapy in narrow QRS study (RethinQ study): methods and protocol design.

Authors:  John F Beshai; Richard Grimm
Journal:  J Interv Card Electrophysiol       Date:  2007-09       Impact factor: 1.900

Review 8.  Devices in the management of advanced, chronic heart failure.

Authors:  William T Abraham; Sakima A Smith
Journal:  Nat Rev Cardiol       Date:  2012-12-11       Impact factor: 32.419

9.  Demonstration of left ventricular dyssynchrony and resynchrony by ECG-gated SPECT with cardioGRAF in a patient with advanced heart failure and narrow QRS complex.

Authors:  Itsuro Morishima; Takahito Sone; Hideyuki Tsuboi; Hiroaki Mukawa; Michitaka Uesugi; Kazunori Hayashi
Journal:  J Interv Card Electrophysiol       Date:  2009-01-16       Impact factor: 1.900

10.  Expanding indications for resynchronization therapy.

Authors:  Christophe Leclercq; Nathalie Behar; Philippe Mabo; Jean-Claude Daubert
Journal:  Curr Cardiol Rep       Date:  2012-10       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.